Gainers Basel Medical Group (NASDAQ:BMGL) shares moved upwards by 59.8% to $7.32 during Monday'

Initial Advance of $2.5 Million to Realbotix LLC to Support Growth and Working Capital; Non-Interest

Initial Advance of $2.5 Million to Realbotix LLC to Support Growth and Working Capital; Non-Interest

LAS VEGAS--(BUSINESS WIRE)--Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbot

Gainers InnovAge Holding (NASDAQ:INNV) shares increased by 10.8% to $11.65 during Tuesday's aft

Gainers iSpecimen (NASDAQ:ISPC) stock increased by 22.7% to $1.89 during Tuesday's pre-market s

iSpecimen surged 27.9% premarket on a $4.5M Foldlab AI asset deal; CEA Industries led gainers, while

Gainers iSpecimen (NASDAQ:ISPC) shares increased by 10.4% to $1.7 during Friday's after-market

Pilot Tests Humanoid Robots as Presenters, Hosts, and Brand Ambassadors Before Live Audiences, Exten

Entertainment Industry Agreement Reflects Real-World Adoption of Humanoid Robotics Technology Across

Proteomedix Co-Founder and Proclarix® Co-Developer Returns to Company's Board; Thomas Meier, PhD Re-

Gainers Nuwellis (NASDAQ:NUWE) stock rose 40.2% to $2.65 during Wednesday's after-market sessio

Gainers Tenet Healthcare (NYSE:THC) stock increased by 17.3% to $233.54 during Friday's regular

[url="]Realbotix Corp.[/url] (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) ("Realbotix" or the "Com

Realbotix Robots and AI to Deploy in Evidence-Based Pilot Designed to Improve Wellbeing and Address

Salamanca City Central School District on Seneca Nation Reservation to Deploy Optio and Realbotix M-

VANCOUVER, BC / ACCESS Newswire / June 23, 2026 / Onco-Innovations Limited (NEO:ONCO)(OTCQB:ONNVF)(F

Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 40.3% to $4.56 during Tuesday's after-m

Not for distribution to United States wire services or for dissemination in the United States VANCOU

Also Announces Appointment of Mr. Dave Antony as CFO VANCOUVER, BC / ACCESS Newswire / June 19, 2026

STOCKHOLM — June 17, 2026 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company speci

VANCOUVER, BC / ACCESS Newswire / June 16, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNV

[url="]Realbotix Corp[/url]. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbotix” or the

US stocks down, Nasdaq drops 200 points. Dow -0.35% at 49,512.48, Nasdaq -0.93% at 25,849.08, S&

US stocks fall, Dow Jones down 0.34% & NASDAQ down 0.41% in morning trading. Home Depot reports

Onconetix, Inc. (NASDAQ:ONCO) ("Onconetix" or the "Company"), a commercial-stage bio

[url="]Realbotix Corp.[/url] (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbotix” or the

CINCINNATI, Ohio, May 19, 2026 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (“Onconetix” or th

LAS VEGAS--(BUSINESS WIRE)--Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbot

Agilysys Inc (AGYS) shares rose in pre-market trading after reporting better-than-expected financial

Onconetix Inc. shares soared 23.65% after hours following clinical progress updates, new study initi

Onconetix Inc. shares soared 23.65% after hours following clinical progress updates, new study initi

Onconetix (NASDAQ:ONCO) reported quarterly losses of $(6.71) per share. This is a 97.02 percent incr

New Clinical Data Reinforce Proclarix Performance in Reducing Overdiagnosis and Unnecessary Biopsies

Organon & Co (OGN) jumped 14.8% in pre-market trading as Sun Pharma agreed to acquire the compan

Onconetix shares are surging Thursday afternoon after the company highlighted a product milestone fr

Dow up 0.77% to 48,278.43, NASDAQ up 0.83% to 22,822.04, S&P 500 up 0.69% to 6,829.76. Utilities

Onconetix, Inc. (Nasdaq: ONCO) ("Onconetix" or the "Company") is providing the follo